Nkarta (NKTX) Change in Acquisitions & Divestments (2020 - 2026)
Nkarta's quarterly Change in Acquisitions & Divestments came in at $70.6 million in Q1 2026, down 6.4% year-on-year from $75.4 million in Q1 2025, and down 24.15% quarter-over-quarter from $93.1 million in Q4 2025.
Nkarta has reported Change in Acquisitions & Divestments for 7 years, with the latest figure at $70.6 million in Q1 2026.
- For the quarter ending Q1 2026, Change in Acquisitions & Divestments fell 6.4% year-over-year to $70.6 million; the trailing twelve-month figure through Mar 2026 stood at $335.3 million (up 13.66% YoY), and the FY2025 full-year result was $340.1 million, up 20.93% from the prior year.
- Change in Acquisitions & Divestments for Q1 2026 stood at $70.6 million, down from $93.1 million in the prior quarter.
- The five-year high for Change in Acquisitions & Divestments was $126.0 million in Q1 2023, with the low at $29.2 million in Q1 2022.
- Average Change in Acquisitions & Divestments over 5 years is $76.9 million, with a median of $75.4 million recorded in 2025.
- Year-over-year, Change in Acquisitions & Divestments sank 53.69% in 2022 and surged 331.41% in 2023.
- Tracing NKTX's Change in Acquisitions & Divestments over 5 years: stood at $115.4 million in 2022, then dropped by 25.45% to $86.0 million in 2023, then decreased by 4.3% to $82.3 million in 2024, then grew by 13.1% to $93.1 million in 2025, then dropped by 24.15% to $70.6 million in 2026.
- The last three Change in Acquisitions & Divestments figures came in at $70.6 million (Q1 2026), $93.1 million (Q4 2025), and $83.2 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Nkarta | 232.80 Mn | 232.80 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 70.61 Mn |
| Mar 31, 2026 | 70.61 Mn |
| Dec 31, 2025 | 93.08 Mn |
| Dec 31, 2025 | 93.08 Mn |
| Sep 30, 2025 | 83.16 Mn |
| Sep 30, 2025 | 83.16 Mn |
| Jun 30, 2025 | 88.42 Mn |
| Jun 30, 2025 | 88.42 Mn |
| Mar 31, 2025 | 75.44 Mn |
| Mar 31, 2025 | 75.44 Mn |
| Dec 31, 2024 | 82.30 Mn |
| Dec 31, 2024 | 82.30 Mn |
| Sep 30, 2024 | 68.23 Mn |
| Sep 30, 2024 | 68.23 Mn |
| Jun 30, 2024 | 69.00 Mn |
| Jun 30, 2024 | 69.00 Mn |
| Mar 31, 2024 | 61.70 Mn |
| Mar 31, 2024 | 61.70 Mn |
| Dec 31, 2023 | 86.00 Mn |
| Dec 31, 2023 | 86.00 Mn |
| Sep 30, 2023 | 75.00 Mn |
| Sep 30, 2023 | 75.00 Mn |
| Jun 30, 2023 | 80.36 Mn |
| Jun 30, 2023 | 80.36 Mn |
| Mar 31, 2023 | 126.04 Mn |
| Mar 31, 2023 | 126.04 Mn |
| Dec 31, 2022 | 115.36 Mn |
| Dec 31, 2022 | 115.36 Mn |
| Sep 30, 2022 | 63.86 Mn |
| Sep 30, 2022 | 63.86 Mn |
| Jun 30, 2022 | 39.87 Mn |
| Jun 30, 2022 | 39.87 Mn |
| Mar 31, 2022 | 29.22 Mn |
| Mar 31, 2022 | 29.22 Mn |
| Dec 31, 2021 | 79.43 Mn |
| Dec 31, 2021 | 79.43 Mn |
| Sep 30, 2021 | 137.91 Mn |
| Sep 30, 2021 | 137.91 Mn |
| Jun 30, 2021 | 31.50 Mn |
| Jun 30, 2021 | 31.50 Mn |
| Mar 31, 2021 | 16.00 Mn |
| Mar 31, 2021 | 16.00 Mn |
| Sep 30, 2020 | 3.90 Mn |
| Sep 30, 2020 | 3.90 Mn |
| Jun 30, 2020 | 5.30 Mn |
| Jun 30, 2020 | 5.30 Mn |
| Mar 31, 2020 | 10.80 Mn |
| Mar 31, 2020 | 10.80 Mn |